FDA Adverse Event Injury Summary report: N

ALARIS SYRINGE MODULE

MDR report key: 3862977 · Received June 4, 2014

Report

Report Number
2016493-2014-00254
Event Type
Injury
Date Received
June 4, 2014
Date of Event
May 5, 2014
Report Date
May 7, 2014
Manufacturer
CAREFUSION CORP
Product Code
FRN
PMA / PMN Number
K023264
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
BIOMEDICAL ENGINEER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DATA SET, DEVICE LOGS AND SYRINGE MODULE HAVE BEEN RECEIVED AND THE EVALUATION IS PENDING. A FOLLOW UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS ONCE THE EVALUATION IS COMPLETED.

Description of Event or Problem · 1

THE CUSTOMER REPORTED AN OVER INFUSION OF LIPIDS IN THE NICU. A 60 ML SYRINGE CONTAINING 52 ML LIPIDS WAS INSTALLED AT AROUND 4 PM ON (B)(6) 2014 TO "INFUSE ALL" AT THE RATE OF ABOUT 2.2 ML/HR AND WAS EXPECTED TO LAST ABOUT 24 HOURS. THE SYRINGE WAS DISCOVERED TO BE EMPTY AT AROUND 5 AM ON (B)(6) 2014. TRIGLYCERIDE LEVEL WAS DRAWN AND THE LEVEL WAS REPORTED TO BE HIGH (SPECIFIC LEVEL NOT PROVIDED). OTHER THAN THE ELEVATED TRIGLYCERIDES, THE PT HAD NO ADVERSE EFFECT AND IS CURRENTLY DOING WELL. ALTHOUGH REQUESTED, NO FURTHER PT OR EVENT INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
326122 ALARIS SYRINGE MODULE SYRINGE PUMP FRN CAREFUSION CORP 8110 NA

Patients

Seq Age Sex Outcome Treatment
1 UNK Other ALARIS PC UNIT, SN (B)(4)| EXTENSION TUBING SET, MFR/MODEL/LOT UNK